Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-042492

Co-Chief Executive Officer gave up 1,621 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 4,687 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-07-10 Option exercise +4,687 103,005 D
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-07-10 Shares withheld for taxes −1,621 $2.20 $3,566 101,384 D
Derivatives
MOHANTY ADITYA P. Co-Chief Executive Officer 2018-07-10 Option exercise · Restricted Stock Units −4,687 32,813 D
Loading xslF345X03/doc4.xml…